Following a handover, Dr Andrew Saunders will leave the company after 3 years to persue other opportunities. Robertson, a well respected UK haemato-oncologist, will join RedX from Achilles Therapeutics, where she was serving as a CMO, too. Prior to that, she held the same position of CMO at Nucana Biomed Ltd and Kesios Therapeutics Ltd. For more than 12 years, she worked at AstraZeneca. Robertson studied Medicine in Oxford, London and Manchester, where she also earned her doctorate.